Defiance ETFs Launches first US-listed ETF focused on psychedelics

Defiance ETFs has launched the Defiance Next Gen Altered Experience ETF ($PSY), the first psychedelic ETF to be listed in the US. 

$PSY will give investors exposure to companies involved in the development of the next generation of medicine, including psychedelics, cannabis and other psychedelic derived treatments.

The Psychedelic ETF ($PSY) joins Defiance's suite of first-mover disruptive ETFs, hich includes Next Gen H2 ($HDRO), the first SPAC ETF ($SPAK),  and the first 5G ETF ($FIVG).